Eastern Bank’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Eastern Bank's TVTX Position: Q3 2026 in Review
Eastern Bank held its Travere Therapeutics (TVTX) position steady in Q3 2026 at 325 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #813.
Eastern Bank first reported a position in TVTX in Q1 2026 and has held it in 3 quarters since. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Eastern Bank held 325 shares of Travere Therapeutics worth $19.1K as of Q3 2026.
- Eastern Bank left its Travere Therapeutics share count unchanged in Q3 2026.
- Travere Therapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #813 holding.
- Eastern Bank first reported a position in Travere Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.